Literature DB >> 32972640

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.

Lorraine Lipscombe1, Sonia Butalia2, Kaberi Dasgupta3, Dean T Eurich4, Lori MacCallum5, Baiju R Shah6, Scot Simpson7, Peter A Senior8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32972640     DOI： 10.1016/j.jcjd.2020.08.001

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN： 1499-2671            Impact factor:   4.190


× No keyword cloud information.
  20 in total

1.  Hypoglycemia in type 2 diabetes: It is common, so what strategies can minimize the risk?

Authors:  Marlys LeBras; Tessa Laubscher
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275

2.  Rapid recommendations: Updates from 2020 guidelines: part 1.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

3. 

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

4.  A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country.

Authors:  Nancy Zaghloul; Ahmed Awaisu; Ahmed Mahfouz; Sumaya Alyafei; Hazem Elewa
Journal:  Int J Clin Pharm       Date:  2022-09-28

5.  Remote Pharmacist-Assisted Flash Continuous Glucose Monitoring Improves Glycemic Outcomes in Patients With Poorly Controlled Diabetes: A Retrospective Case Series.

Authors:  Rick Siemens
Journal:  Clin Diabetes       Date:  2022-04-15

6.  Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease.

Authors:  Andrea Cowan; Nivethika Jeyakumar; Yuguang Kang; Stephanie N Dixon; Amit X Garg; Kyla Naylor; Matthew A Weir; Kristin K Clemens
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-26       Impact factor: 10.614

Review 7.  Prevention of Cardiorenal Complications with Sodium-Glucose Cotransporter Type 2 Inhibitors: A Narrative Review.

Authors:  Manuel Botana; Javier Escalada; Ángel Merchante; Rebeca Reyes; Pedro Rozas
Journal:  Diabetes Ther       Date:  2022-06-15       Impact factor: 3.595

Review 8.  Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials.

Authors:  John R Ussher; Amanda A Greenwell; My-Anh Nguyen; Erin E Mulvihill
Journal:  Diabetes       Date:  2022-02-01       Impact factor: 9.461

9.  Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study.

Authors:  Jean-François Yale; Andrei-Mircea Catarig; Katrine Grau; Stewart Harris; Agnieszka Klimek-Abercrombie; Rémi Rabasa-Lhoret; Laura Reardon; Vincent Woo; Joanne Liutkus
Journal:  Diabetes Obes Metab       Date:  2021-08-15       Impact factor: 6.408

Review 10.  Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date.

Authors:  Wajd Alkabbani; John-Michael Gamble
Journal:  Drug Des Devel Ther       Date:  2021-07-14       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.